Announcing the 2014 Symposium Agenda

SymposiumThe agenda for our upcoming 2014 Symposium is now available for viewing! Even though it is still being refined, we wanted you to be the first ones to see the amazing events we have in store for you!

This year, we will host two concurrent events. The International Symposium on Malignant Mesothelioma, a conference for the entire meso community now in its 11th year, will be complemented by a scientific seminar. As always, our Symposium is geared towards attendees from all walks of life, including patients and their families, advocates, medical professionals, and those who have lost a loved one to this disease.

The Mesothelioma Scientific Seminar is a program for scientists and medical professionals only. In order to encourage and facilitate the highest level of information-sharing, collaboration and learning, these sessions are not open to the general public. However, the renowned physicians presenting and attending the Seminar will be available to interact with Symposium attendees outside of their sessions.

About the International Symposium on Malignant Mesothelioma
On Wednesday, March 5, we will kick off the Symposium with Advocacy day. Advocacy presentations by government experts will prepare us for our meetings on Capitol Hill with our elected officials, to educate them and to advocate for increased federal funding of mesothelioma.

On Thursday and Friday, we will cover many topics relating to mesothelioma, from scientific panels to community conversations. Both days will also feature special community dinners to celebrate our award recipients, and our inspiring community. The Meso Fighters Band, composed of individuals directly affected by mesothelioma, will take the stage on Friday night to entertain us with their music.

A “Celebration of Life” tribute ceremony, taking place on Thursday, will honor our loved ones lost to mesothelioma.

Symposium Speakers

General Steven Blum
Raffit Hassan, MD, National Cancer Institute
Hedy Lee Kindler, MD, University of Chicago
Andrew Haas, MD, PhD, University of Pennsylvania
Lee Krug, MD, Memorial Sloan-Kettering Cancer Center
Kenneth Rosenzweig, MD, The Mount Sinai Hospital
Dan Miller, MD, Emory University
Marc dePerrot, MD, University of Toronto
James Pingpank, MD, University of Pittsburgh
Liz Darlison, Mesothelioma UK
Robert Taub, MD, PhD, Columbia Presbytarian
H. Richard Alexander, MD, University of Maryland
Michele Carbone, MD, PhD, University of Hawaii
Andrew Todd, PhD, The Mount Sinai Hospital
Faris Farassati, PhD, PharmD, University of Kansas
Andreas Rimner, MD, Memorial Sloan-Kettering Cancer Center
Charles Simone, MD, University of Pennsylvania
Evan Alley, MD, University of Pennsylvania
Thierry Jahan, MD, UC – San Francisco
Anne Tsao, MD, MD Anderson

Scientific Seminar Speakers

H. Richard Alexander, MD, University of Maryland
Michele Carbone, MD, PhD, University of Hawaii
Joost Hegmans, Erasmus Medical Center Rotterdam
Mitchel Cheung, PhD, Fox Chase Cancer Center
Dario Barbone, PhD, UC-San Francisco
Filippo Giancotti, MD, PhD, Memorial Sloan-Kettering Cancer Center
Il-Jin Kim, PhD, UC-San Francisco
Valerie Rusch, MD, FACS, Memorial Sloan-Kettering Cancer Center
Kenneth Rosenzweig, MD, The Mount Sinai Hospital
Marc DePerrot, MD, University of Toronto
Sheelu Varghese, PhD, University of Maryland
Mitchell Keegan, PhD
Marjorie Zauderer, MD, Memorial Sloan-Kettering Cancer Center
Alessandra DiPietro, PhD
Lee Krug, MD, Memorial Sloan-Kettering Cancer Center
Daniel Sterman, MD, University of Pennsylvania
Andrew Haas, MD, PhD, University of Pennsylvania
Robert Kratzke, MD, University of Minnesota
Ira Pastan, MD and Raffit Hassan, MD, National Cancer Institute
Alain Borczuk, MD, Columbia University
Robert Taub, MD, Columbia Presbytarian
Laura Lambert, MD, University of Massachusetts
Garrett Nash, MD, Memorial Sloan-Kettering Cancer Center
Jesus Esquivel, MD, Cancer Treatment Centers of America
Kiran Turaga, MD, The Medical College of Wisconsin
Paul Sugarbaker, MD, University of Washington
Jason Foster, MD, University of Nebraska
David Bartlett, MD, University of Pittsburgh

You won’t want to miss any of the events of this Symposium, so start making your plans to attend! Registration and hotel reservations can be easily made at www.curemeso.org/symposium.

FROM THE HEADLINES: 2012 Symposium Speaker Dr. Raja Flores on the Lasting Toll of 9-11

Dr. Raja Flores, chief of thoracic surgery at Mount Sinai School of Medicine and a featured speaker at our 2012 Symposium in Washington D.C., spoke to FoxNews.com about the adverse health effects some of those first responders have faced. The article reports that Mount Sinai researchers have been following approximately 30,000 first responders, many of whom were breathing in dust containing 2,000 tons of asbestos on a daily basis as they cleaned up the site. The researchers found 30 percent had problems with asthma, 40 percent had sinus problems, and another 40 percent had gastro-esophageal reflux, which is a precursor to esophageal cancer.

You can also watch the accompanying video here.

If you want to hear more from Dr. Flores, make plans to join us at the 2012 Symposium on Thursday, July 12, (9:45 a.m. – 12:00 Noon) to participate in the panel “Demystifying Scientific Breakthroughs” panel. Along with Dr. Flores,  the latest in mesothelioma research will be presented by Stephen Hahn, MD, Raffit Hassan, MD, Robert Kratzke, MD, Harvey Pass, MD, Daniel Sterman, MD, David Sugarbaker, MD.

Click here to preview the 2012 Symposium agenda.